Giovanna Fontgalland-Ferreira

Dr. Giovanna Fontgalland-Ferreira

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GMGlaucia Gonçales Abud Machado
Glaucia Gonçales Abud Machado
GFGiovanna Fontgalland-Ferreira
Giovanna Fontgalland-Ferreira
EMERIKA DA SILVA MELLO
ERIKA DA SILVA MELLO
EAEllen Sayuri Ando-Suguimoto
Ellen Sayuri Ando-Suguimoto
VRVinicius Leão Roncolato
Vinicius Leão Roncolato
AHAnna Carolina Ratto Tempestini Horliana
Anna Carolina Ratto Tempestini Horliana
The evidence for photobiomodulation in reducing postoperative pain after endodontic instrumentation is classified as low or very low certainty, indicating a need for further research. Longitudinal pain assessments over 24 h are crucial, and studies should explore these pain periods. Background/Objectives: This double-blind, randomized controlled clinical trial evaluated the effect of PBM on pain following single-visit endodontic treatment of maxillary molars at 4, 8, 12, and 24 h. Primary outcomes included pain at 24 h; secondary outcomes included pain at 4, 8, and 12 h, pain during palpation/percussion, OHIP-14 analysis, and frequencies of pain. Methods: Approved by the Research Ethics Committee (5.598.290) and registered in Clinical Trials (NCT06253767), the study recruited adults (21–70 years) requiring endodontic treatment in maxillary molars. Fifty-eight molars were randomly assigned to two groups: the PBM Group (n = 29), receiving conventional endodontic treatment with PBM (100 mW, 333 mW/cm2, 9 J distributed at 3 points near root apices), and the control group (n = 29), receiving conventional treatment with PBM simulation. Pain was assessed using the Visual Analog Scale. Results: Statistical analyses used chi-square and Mann–Whitney tests, with explained variance (η2). Ten participants were excluded, leaving 48 patients for analysis. No significant differences were observed in postoperative pain at 24, 4, 8, or 12 h, or in palpation/percussion or OHIP-14 scores. Pain frequencies ranged from 12.5% to 25%. Conclusions: PBM does not influence post-treatment pain in maxillary molars under these conditions. These results emphasize the importance of relying on well-designed clinical trials to guide treatment decisions, and future research should focus on personalized dosimetry adapted to the anatomical characteristics of the treated dental region to enhance the accuracy and efficacy of therapeutic protocols.

5 September 2026 in Lasers in Medical Science
Verified
Journal Article
Open access
PDF file
GFGiovanna Fontgalland-Ferreira
Giovanna Fontgalland-Ferreira
SFSarah Marinho Figueiredo
Sarah Marinho Figueiredo
KMKARLA NOGUEIRA MATOS
KARLA NOGUEIRA MATOS
VRVinicius Leão Roncolato
Vinicius Leão Roncolato
CKClaudio Teruo Kassa
Claudio Teruo Kassa
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
Fungal infections caused by Candida albicans and Candida auris represent an increasing clinical challenge, particularly due to biofilm formation and rising antifungal resistance. Antimicrobial photodynamic therapy (aPDT) has emerged as a potential alternative strategy, with phenothiazine-based photosensitizers being among the most extensively investigated compounds. This systematic review aimed to evaluate the application of phenothiazine-mediated aPDT in in vitro studies against C. albicans and C. auris . A comprehensive search was conducted in PubMed, Embase, and Scopus, including studies published within the last 10 years. Forty in vitro studies met the eligibility criteria and were synthesized descriptively due to substantial methodological heterogeneity. Overall, aPDT was associated with reductions in fungal viability, with generally greater effects reported in planktonic models compared with biofilms. Methylene blue was the most frequently investigated photosensitizer, applied across a broad range of concentrations and dosimetric parameters, resulting in variable antifungal responses. Other phenothiazine derivatives, including toluidine blue O, dimethyl methylene blue, new methylene blue, and S137, were also associated with antifungal activity under specific experimental conditions but remain comparatively underexplored. Studies involving C. auris were less frequent and suggested lower susceptibility compared with C. albicans , particularly in biofilm models. Given the substantial variability in experimental protocols, especially regarding photosensitizer concentration, light parameters, and biofilm maturation, the findings should be interpreted with caution and limit direct comparison across studies. These findings support the antifungal potential of phenothiazine-mediated aPDT while emphasizing the need for methodological standardization and expanded investigation of C. auris.

27 September 2026 in Journal of Oral Biology and Craniofacial Research
Verified
Journal Article
Open access
KMKARLA NOGUEIRA MATOS
KARLA NOGUEIRA MATOS
GFGiovanna Fontgalland-Ferreira
Giovanna Fontgalland-Ferreira
MAMarcos de Faria Almeida
Marcos de Faria Almeida
LALeonardo Matos de Faria Almeida
Leonardo Matos de Faria Almeida
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
HGHugo Henrique dos Santos Dantas Guimarães
Hugo Henrique dos Santos Dantas Guimarães